Akanda (AKAN) Other Non-Current Assets (2022 - 2025)
Akanda's (AKAN) quarterly Other Non-Current Assets came in at $3.8 million in Q4 2025, up 264.22% year-on-year from $1.1 million in Q4 2024, and up 264.22% quarter-over-quarter from $1.1 million in Q4 2024.
Akanda (AKAN) Other Non-Current Assets (2022 - 2025) Analysis & Trends
Akanda's Other Non-Current Assets history runs 4 years deep, the most recent figure standing at $3.8 million for Q4 2025.
- On a quarterly basis, Other Non-Current Assets rose 264.22% year-over-year to $3.8 million in Q4 2025; TTM through Dec 2025 was $3.8 million, a 264.22% increase from a year earlier, with the FY2025 full-year figure at $3.8 million, up 264.22% from the prior year.
- Other Non-Current Assets grew to $3.8 million in Q4 2025 per AKAN's latest filing, from $1.1 million in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $7.4 million in Q4 2023 and bottomed at $819376.0 in Q4 2022.
- The 4-year median for Other Non-Current Assets is $2.4 million (2024), against an average of $3.3 million.
- Across the five-year window, Other Non-Current Assets soared 805.73% in 2023 and sank 85.82% in 2024, its largest moves.
- Year by year, Other Non-Current Assets stood at $819376.0 in 2022, then surged by 805.73% to $7.4 million in 2023, then sank by 85.82% to $1.1 million in 2024, then jumped by 264.22% to $3.8 million in 2025.
- Per Business Quant, the three latest AKAN Other Non-Current Assets figures stand at $3.8 million (Q4 2025), $1.1 million (Q4 2024), and $7.4 million (Q4 2023).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 49.22 Mn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 1.79 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 351.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 491.06 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 233.20 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.11 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 73.60 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 295.00 Mn |
| 10 | Akanda | 556,353.85 | 556,353.85 | - | 3.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3.83 Mn |
| Dec 31, 2024 | 1.05 Mn |
| Dec 31, 2023 | 7.42 Mn |
| Dec 31, 2022 | 819,376.00 |